-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Intellipharmaceutics International Inc. annual/quarterly Depreciation history and growth rate from Q1 2016 to Q2 2017.
- Intellipharmaceutics International Inc. Depreciation for the quarter ending May 31, 2017 was CA$107K, a 13.8% increase year-over-year.
- Intellipharmaceutics International Inc. annual Depreciation for 2018 was CA$613K, a 17.6% increase from 2017.
- Intellipharmaceutics International Inc. annual Depreciation for 2017 was CA$521K, a 35.2% increase from 2016.
- Intellipharmaceutics International Inc. annual Depreciation for 2016 was CA$385K, a 1.95% increase from 2015.
Depreciation, Quarterly (CAD)
Depreciation, YoY Quarterly Growth (%)